Daiwa Securities Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3K | Hold |
206
| – | – | ﹤0.01% | 1199 |
|
2025
Q1 | $3K | Buy |
+206
| New | +$3K | ﹤0.01% | 1168 |
|
2022
Q4 | – | Sell |
-4
| Closed | – | – | 1373 |
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1383 |
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1410 |
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1403 |
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1433 |
|
2021
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 1278 |
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1208 |
|
2021
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 1222 |
|
2020
Q4 | $1K | Sell |
4
-6
| -60% | -$1.5K | ﹤0.01% | 1201 |
|
2020
Q3 | $2K | Buy |
10
+4
| +67% | +$800 | ﹤0.01% | 1134 |
|
2020
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 1178 |
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 1187 |
|
2019
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1176 |
|
2019
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1146 |
|
2019
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 1167 |
|
2019
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 1154 |
|